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Capsid functionenerated by transfecting 293T cells with three sets of DNAs: DNA for the
expression of simian virus 40 (SV40) T antigen; DNA for the expression of SV40 capsid proteins, and vector
DNA harboring a reporter gene expression cassette carrying a SV40 origin. The vector DNA harbors a minimal
sequence originating from SV40, and thus can carry a longer transgene. Moreover, the viable recombinants
are not detectable in the vector preparation, and the vectors can transduce the DNAwith efﬁciency similar to
that of virions. Vector particles bearing capsid proteins of BK virus, JC virus, and B-lymphotropic papovavirus
instead of SV40 were prepared, and they exhibited differential efﬁciency of gene transduction to the target
cells. This method can be used to develop a surrogate system to study the functions of capsid proteins of
polyomaviruses and to generate a set of polyomaviral vectors targeted at speciﬁc cell types.
© 2008 Elsevier Inc. All rights reserved.Introduction
Simian virus 40 (SV40) is a polyomavirus, a non-enveloped small
DNA virus whose capsid is composed of major capsid protein Vp1 that
forms a pentamer, 72 of which are arranged as an iosahedral capsid
shell, and minor capsid proteins Vp2 and Vp3, one of which resides in
the inner cavity of the Vp1 pentamer (Imperiale and Major, 2007).
Packaged inside the capsid in a minichromosomal form is the double-
stranded circular viral DNA of about 5 kbp in size, which can be
divided into three elements: (1) the early region, encoding T antigen
proteins essential for viral DNA replication and viral gene expression;
(2) the late region, encoding Vp1, Vp2, Vp3, and agno protein; and (3)
the regulatory region, including the origin of replication and
promoters for the expression of genes in the early and late regions.
In addition to representative polyomaviruses, such as SV40, murine
polyomavirus, JC virus (JCV), BK virus (BKV), and monkey B-
lymphotropic papovavirus (LPV), three new human polyomaviruses
have been recently reported: Merkel cell polyomavirus (Feng et al.,
2008), associated with the rare skin cancer Merkel cell carcinoma and
two related viruses, WU virus (Gaynor et al., 2007) and KI virus
(Allander et al., 2007), which were described in clinical specimens.
The built-in afﬁnity of viral structural proteins for the natural
target cells is often the determinant of virus tropism. Among theartment of Aging Intervention,
er for Geriatrics and Gerontol-
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l rights reserved.polyomaviruses, JCV and LPV exhibit highly restricted cell tropism. JCV
infection is restricted to oligodendrocytes, astrocytes, and B-lympho-
cytes (Assouline and Major, 1991; Major et al., 1990; Major et al., 1985;
Major and Vacante, 1989), whereas LPV only infects cells of the B-
lymphocyte lineage (Brade et al., 1981; Takemoto et al., 1982).
Restriction involves the ability of the viral capsid protein to interact
with cell surface receptors (JCV, (Chen and Atwood, 2002; Wei, Liu,
and Atwood, 2000); LPV, (Haun et al., 1993; Herrmann, Oppenlander,
and Pawlita, 1995)). Thus, one would expect that gene transfer
performed using such capsids to be restricted to group of cells of the
natural target.
SV40 has been studied as a viral vector with an emphasis on the
ease of producing high-titer stocks (Strayer and Milano, 1996) and its
ability to transduce genes to many cell types (Kimchi-Sarfaty et al.,
2002; Strayer et al., 2002). The vector can package up to 7 kbp of
circular DNA, albeit poorly when the size exceeds 5 kbp (Oppenheim
et al., 1992), and partial degradation of the oversized DNA upon
packaging is also observed (Chang and Wilson, 1986). However,
transgene size that can be carried into the vector is only a few
kilobases (Strayer, 1996), owing to the built of the vector DNA that was
developed from a defective viral variant lacking the T antigen coding
sequence (Oppenheim and Peleg, 1989). The vector efﬁciently
propagates in Cos cells constitutively expressing T antigen from
defective SV40 DNA integrated into the cellular DNA. It is also prone to
the generation of wild-type like recombinants, likely because of
recombinations between the vector DNA and defective viral DNA in
the host DNA. Such deﬁciency encouraged the production of alternate
cell lines constitutively expressing T antigen driven by non-SV40
Fig. 1. Production of particles packaging vector DNA. (A) Lysates of the 293T cells
transfectedwith DNAs for producing virion (SV40, top panel), vector particles packaging
pSEAP2 DNA (pSEAP2, middle panel), and empty particles (No vector DNA, bottom
panel) were sedimented through Optiprep gradients and fractionated from the top. A
10-μl aliquot of each fraction was detected for SV40 Vp1 by Western blotting. (B)
Detection of DNA transduction activity. Ten microliter aliquots of each fraction from
pSEAP2 in (A) were applied to 293FT cells, incubated for 48 h, and SEAP activity in the
15-μl cell culture medium was measured. Vertical axis represents arbitrary values of
relative SEAP activity in themedium. (C) Composition of capsid proteins in the Vp1 peak
fractions. The Vp1 peak fractions of SV40 (SV40, lanes 1, 2, 3, and 10), vector particles
(pSEAP2, lanes 4, 5, 6, and 11), and SV40-luc (SV40-luc, lanes 7, 8, 9, and 12) were
adjusted for DNA, separated by SDS-PAGE, and examined for either Vp1 (left panel) or
Vp3 (right panel) by Western blotting. Samples containing 1×105 (lanes 1, 4, and 7),
3×105 (lanes 2, 5, and 8), and 1×106 (lanes 3, 6, and 9) copies of the DNAwere applied to
each lane. In the right panel (lanes 10–13), samples contained 5×107 copies of the DNA
for virion (SV40, lane 10), vector particles (pSEAP2, lane 11), and SV40-luc (SV40-luc,
lane 12).
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2002). Alternatively, in vitro encapsulation of DNA using recombinant
SV40 capsid proteins was used to generate vector particles (Kimchi-
Sarfaty et al., 2002).
Here we made polyomaviral vectors that were able to carry longer
transgenes without detectable contamination with wild-type-like
recombinants. Using this method, we were able to use capsids of any
one of the polyomaviruses SV40, JCV, LPV, and BKV to package the
vector DNA. Such vector particles exhibited distinct and differential
abilities to transduce DNA to the target cells depending on the capsid
used. The method can be used for generating both surrogate systems
for studying viral capsid proteins of other polyomaviruses and cell
type-restricted gene transfer vectors.
Results
Vector particle production by transient transfection to 293T cells
First, SV40 vectors were made by a transient transfection-based
approach. Four DNA constructs, pCI-Ts, pTRE-Vps, mpTet-on, and
pSEAP2, were used to generate SV40 vectors. pCI-Ts is used to express
SV40 T antigen, which promotes the replication of DNA carrying the
SV40 origin and enhancer elements (SV40 Ori), the sequence of which
also serves as a packaging signal (Oppenheim et al., 1992). pTRE-Vps,
harboring SV40 capsid protein genes under the control of the
tetracycline-inducible promoter, and pmTet-on, which expresses the
tetracycline-dependent transcriptional activator (rtTA), were intro-
duced together for the expression of capsid proteins upon addition of
the tetracycline analogue 24 h post-transfection (hpt). pSEAP2 carries
SV40 Ori that also serves as the promoter for expressing the secreted
form of embryonic alkaline phosphatase (SEAP). The four DNAs were
transfected into 293Tcells to generate the vectors. Similar sets of DNAs
in which pSEAP2 was replaced with pUC19 were transfected into the
cells to produce “empty” particles that did not package vector DNA.
SV40 viral DNA was independently transfected into 293T cells to
produce wild-type virion. The transfected cells were collected at 68–
72 hpt and were extracted for particles. The extracts were then
sedimented through a 27%–39% Optiprep continuous gradient.
Eighteen fractions were taken from the top of the gradient, and each
fraction was examined for the presence of Vp1 by Western blotting
(Fig. 1A). Upon sedimenting the extract of cells transfected with SV40
DNA, a Vp1 peak appeared near the bottom of fractions 13–16,
indicating the production of fast sedimenting species, most likely
virion, in the cells (Fig. 1A, top panel, SV40). Similarly, sedimented
fractions of the vector particle preparation showed a Vp1 peak in
fractions 13–17 (middle panel, pSEAP2). The fractions of the empty
particle preparation showed peaks in fractions 13–16 (bottom panel,
No vector DNA), though the Vp1 peak was slightly shifted toward the
top, judged from the intensity of the Vp1 bands.
Vector particles in the Vp1 peak fractions were detected for their
ability to transduce DNA. An aliquot of each fraction was applied to
293FT cells, and the transduction of DNA was estimated by the
expression of SEAP secreted into the culture medium. High alkaline
phosphatase activity was found in the culture medium of cells
exposed to Vp1 peak fractions 14–17, whereas for cells exposed to
fractions 7–13, there was marginal activity in the medium (Fig. 2B).
These results imply that the Vp1 peak fractions contain vector
particles that can transduce pSEAP2 DNA.
We estimated the ratio of capsid protein to vector DNA in the Vp1
peak fractions to see if the composition of the vector particles was
similar to that of the virions. The respective peak fractions were
pooled and the amount of vector DNA was estimated by quantitative
PCR. As a control, particles of SV40-luc, a SV40 vector of the ﬁrst
generation, were prepared by co-transfecting 293T cells with pCI-Ts
and SV40-luc DNA. The particles were puriﬁed by Optiprep sedimen-
tation and the Vp1 peak fractions were pooled. The amount of DNAcontaining SV40 origin sequence in the pooled Vp1 peak fractions was
1.8×1011 copies/ml for virions, 1×109 copies/ml for pSEAP2 vectors,
and 4.2×109 copies/ml for SV40-luc vectors, but not surprisingly, such
DNAwas undetectable in fractions with empty particles. Based on the
DNA copy number each aliquot of Vp1 peak preparation was adjusted
to contain a similar amount of DNA and then examined for the
presence of Vp1 and Vp3 byWestern blotting. The amounts of Vp1 and
Vp3 found in the Vp1 peak preparations were similar among virions
(Fig. 1C; SV40; lanes 1, 2, 3, and 10), vector particles (pSEAP2; lanes 4,
5, 6, and 11), and SV40-luc (SV40-luc; lanes 7, 8, 9, and 12). We also
tried to examine the amount of histones, the virion component
complexed with viral DNA, in the pooled peak fractions by Western
blotting; though this was unsuccessful because of low selectivity and
sensitivity of the available antibodies to the antigens (data not
shown). However, examination of pooled peak fractions by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) followed by
Fig. 2. DNA transduction by vector particles. (A) Transduction efﬁciency of SV40 virion and SV40 vector particles carrying pSR-ZG (SR-ZG) was examined by challenging Cos7L cells.
Virion-infected cells were detected for Vp1 by indirect immune ﬂuorescence technique. Identical sets of cells were visualized for either ﬂuorescence (FL) or by phase-contrast
microscopy (Phase). (B) 293Tcells grown in 96-well plateswere challengedwith 2×103 pSEAP2-carrying vector particles per cell in the presence of serially diluted rabbit anti-Vp1 IgG
(ﬁlled bars) or rabbit anti-mouse IgG (open bars). The conditioned mediumwas used for measurement of SEAP activity after 48 h of incubation. Horizontal and vertical axes indicate
fold dilutions of anti-Vp1 serum and arbitrary units of SEAP activity, respectively. (C) pSEAP2 DNA transduction by SV40 vector particles. Approximately 2×104 293T, CV-1, Cos7L,
NIT-1, and B16 cells grown in 96-well plates were applied with 10 μl of serially diluted vector particle preparations containing 2×106, 2×105, 2×104, and 2×103 copies of vector DNA,
corresponding to 100, 10, 1, and 0.1 particles/cell, respectively, and the conditioned medium taken 48 h after transduction was used for measuring SEAP activity. Four sets of wells
were used to infect the same numbers of particles, and the mean value and standard deviation of the SEAP activity in each set of infections are shown. (D) Transgenes delivered by
the SV40 vector did not survive in the long term. 293T cells were transduced with the SV40 vector carrying pSR-ZG, and on days 2, 5, 12, and 19, the cells were examined for
ZsGreen-positive cells and the amount of vector DNA by PCR. Closed circles represent proportions of cells positive for ZsGreen ﬂuorescence and open squares represent copy
numbers of vector DNA per cell examined from the extracted DNA.
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positions as histones along with Vp1 and Vp3 (Fig. S1, Supplementary
data). Together we concluded that we were able to produce SV40
vectors packaging pSEAP2 DNA.
Transduction of vector DNA into cells
To ﬁnd out whether the vector particles could transduce DNA as
efﬁciently as virion, vector particles carrying pSR-ZG were generated.
pSR-ZG harbors the expression cassette of a green ﬂuorescent protein,Zoanthus Green (ZsGreen), driven by the SV40 early promoterwith the
HTLV enhancer element (Takebe et al., 1988). Vector particles carrying
pSR-ZG and virions were puriﬁed by Optiprep sedimentation, pooled
for the Vp1 peak fractions, and dialyzed to remove Optiprep. The
number of vector particles or virions estimated by quantitative PCR for
DNA was adjusted and used to infect Cos7L cells. When 107 vector
particles in 1-ml mediumwere applied to 105 cells for 1 h at 37 °C, and
then incubated with 5-ml medium for 48 h, about 11.2% of cells
became ZsGreen-positive (Fig. 2A, bottom panels). When applied with
similar concentration of the virion preparation, about 10.3% of them
Fig. 3. Use of non-SV40 polyomaviral capsid to produce vector particles. (A) Lysates of
293T cells transfected with pSCMV ZG, pCI-Ts, and pCAG DNA carrying expressing
cassette for one of capsid proteins of SV40, JCV, LPV, and BKV were sedimented through
27%–39% Optiprep gradients and fractionated from the top. An aliquot of each fraction
was examined for the presence of vector DNA by PCR, amplifying the SV40 Ori region. In
the right column, pooled DNA peak fractions of vectors (Vector) and the corresponding
infectious particles (Control), adjusted to contain similar amounts of DNA, were
examined for the amount of Vp1 using the respective antibodies (see Materials and
methods). (B) Vector DNA peak fractions were pooled, pelleted by high-speed
centrifugation, resuspended to contain 107–108 vector DNA copies/μl. The samples
were ﬁxed with 2% glutaraldehyde and placed on a glow discharge carbon-coated grid,
stained with 0.2% uranyl acetate, and observed with a Joel JEM1200EX electron
microscope at 100 kV.
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by immunocytochemistry (Fig. 2A, top panels). The results suggest
that the vector particles were able to transduce DNA with efﬁciency
similar to that of virion.
To conﬁrm that DNA transduction was mediated by SV40 capsid,
293T cells were challenged with SV40 vector particles carrying
pSEAP2 in the presence of antibody against either SV40 Vp1 or
mouse IgG (Fig. 2B). In the presence of the highest concentration of
anti-Vp1, almost no SEAP activity was found upon transduction by
vector particles, and as the amount of anti-Vp1 decreased, the SEAP
activity was gradually restored (Fig. 2B, ﬁlled columns). The SEAP
activity was essentially unchanged in the presence of any concentra-
tion of an unrelated antibody, anti-mouse IgG (open columns). These
results indicate that transduction was mediated by the SV40 Vp1
protein of the vector particles.
The SV40 vector has been shown to transduce DNA to a variety of
cell lines (Vera and Fortes, 2004). To determine whether vector
particles had a similar ability, vectors carrying pSEAP2 DNAwere used
to challenge various cell lines: the SV40 permissive monkey cell lines
(Cos7L and CV-1), a SV40-semipermissive human cell line (293T), a
hepatoma cell line (HepG2), and non-permissive rodent cell lines
(melanoma cell line B16 and pancreatic beta cell line NIT-1). As shown
in Fig. 2C, SEAP activity detected in the cell culture medium increased
as a function of the number of particles used to challenge the cells. The
higher activities detected in Cos7L and 293Tcells were probably due to
the presence of constitutively expressed T antigen proteins that could
enhance SEAP expression driven by the SV40 promoter.We did not see
such enhancement in NIT-1 cells, which carry T antigen genes under
the control of the insulin promoter, possibly relates to inability of SV40
T antigen to promote viral DNA replication in mouse cells. Never-
theless, the SV40 capsid-based vector particles exhibited a broad host
range for DNA transduction.
The episomal nature of polyomaviral DNA replication suggests that
without functional T antigen, the vector DNA transduced into the cells
would not survive long. 293T cells transduced with SV40 vector
carrying pSR-ZG were examined for the proportion of transgene-
positive cells upon prolonged culture (Fig. 2D). Not surprisingly, the
proportion of cells positive for ZsGreen had diminished signiﬁcantly
5 days after transduction and became undetectable by 12 days. The
vector DNA detected in the cells had also diminished 12 days after
transduction, indicating that transgenes delivered by the SV40 vector
do not survive long.
Use of vector DNA carrying minimal sequence of viral origin can reduce
the chance of generating viable recombinants
In our method of generating vectors, the SV40 viral elements are
separated into three DNAs. Therefore, at least two recombination
events must occur in order to reconstruct the viable wild-type-like
genome. We expected that our vector production method would be
less prone to the generation of such recombinants. To this end, we
prepared pSCMV-ZG carrying minimal SV40 sequence; the only SV40
sequence was 243 bp encompassing SV40 Ori for replication and
packaging and the remaining sequence comprised the ZsGreen
expression cassette and the bacterial plasmid sequence. Vector
particles carrying pSCMV-ZG were generated in a manner similar to
that described above, by transfection to 293T cells. To represent ﬁrst-
generation SV40 vector, particles carrying SV40-luc were prepared by
transfecting SV40-luc DNA into Cos7L cells and harvested 72 hpt. Both
particles were puriﬁed and quantiﬁed for vector DNA to estimate the
particle number, and were applied to CV-1 cells to test their ability to
make plaques; the presence of a viable recombinant would be
apparent by the generation of plaques. No plaques were visible after
challenge with the vector particle preparation in three independent
trials, even at 1×1010 particles per well plated with about 5×105 cells.
The SV40-luc particle preparation contained viable virus; applicationof about 1×1010 particles generated 3.67±2.08 plaques in three trials,
though all plaques were smaller (b1 mm in diameter) than those
obtained with the wild-type virion (2.73±0.52 mm in diameter). Not
surprisingly, when CV-1 cells were infected with SV40 virion that had
been prepared in 293T cells, 1×1010 virions yielded about 9×106
plaques. Thus, our method can produce vector particles without
detectable contamination with wild-type-like recombinants.
Use of viral capsid of other primate polyomaviruses
We examined if the capsid of non-SV40 polyomaviruses could be
used to prepare vector particles. In this experiment, the late gene
regions of SV40, JCV, LPV, and BKV were cloned into the pCAGGS
plasmid, the expression of which was driven by a hybrid of the hCMV
enhancer and the chicken beta-actin promoter. Each capsid expression
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and the cell extract was sedimented through a 27%–39% Optiprep
gradient. Sixteen fractions were taken from the top and each was
examined for the presence of vector DNA by PCR. Fig. 3A shows the
agarose gel electrophoresis proﬁle of the PCR product ampliﬁed for
SV40 origin. Presence of DNA was apparent in fractions 10 to 13, and
the proﬁle was similar among all vector preparations. The DNA peak of
SV40 vectors was also collinear with that of Vp1 detected by Western
blotting (data not shown). The DNA peak fractions were pooled,
quantiﬁed for DNA, and compared with the capsid protein present in
the preparations along with the puriﬁed virions or infectious particles
(see Materials and methods). Both vector and the infectious particles
were adjusted to contain similar amounts of DNA and tested for Vp1
by Western blotting (Fig. 3A, right columns). All vector preparations
(Vector) appeared to contain similar amounts of Vp1 as the viral
counterpart (Control) suggesting that the packaging efﬁciency of the
vector was comparable to that of the infectious particles. The vector
DNA peak pool was then dialyzed to remove Optiprep, pelleted by
high-speed centrifugation to concentrate the vector particles, and then
observed under an electron microscope (Fig. 3B). Structures closely
resemble to virion particles were visible in all preparations. Contami-
nants that did not resemble polyomaviral particleswere present in a JCV
preparation whose origin was not known (Fig. 3B, lower panel).
Together, the results suggest that capsid proteins of JCV, BKV, and LPV
can package vector DNA ampliﬁed by SV40 Tantigen and form particles.
To ﬁnd out whether such particles can be used as gene transfer
vehicles, particles carrying pSCMV-ZG were used to challenge
SV40-permissive TC7 cells, JCV-permissive SVG cells, LPV-permis-
sive Namalwa cells, BKV-permissive Vero cells, and mouse
myoblastic cells (C2C12). The proportions of transduced cells are
shown in Fig. 4. Upon challenge of TC7 cells (TC7) a ZsGreen signal
was readily found in cells transduced with the SV40 vector; the
remaining vectors were less efﬁcient in generating ZsGreen-positive
cells. Challenge of Vero cells also showed that the SV40 vector was
the most efﬁcient in transducing vector DNA (Vero). Similar results
were obtained using 293T cells (data not shown). In contrast, when
SVG human glial cells were challenged with vectors (SVG), almost
all cells showed positive ZsGreen ﬂuorescence after JCV vector
transduction, whereas the cells that received SV40 and BKV vectors
showed less frequent presence of the positive cells and the least in
the cells received LPV vector. When Namalwa cells were
challenged, none of the vector particles generated signiﬁcant
number of ZsGreen-positive cells (data not shown). Interestingly,
when mouse myoblast C2C12 cells (C2C12) were challenged, LPV
vector transduction appeared to be the most efﬁcient, followed by
the SV40 vector. The remaining vectors did not generate signiﬁcant
numbers of ZsGreen-positive cells. These results indicate thatFig. 4. DNA transduction by vector particles shows different tropism depending on the
capsid used. Cells plated on eight-well Labtek chamber slides received approximately
4×103 vector particles carrying pSCMV-ZG DNA per cell and were incubated for 48 h
before ﬁxation. ZsGreen expression was detected either by the ﬂuorescence of ZsGreen
(SVG) or by indirect immunoﬂuorescence (TC7, Vero, and C2C12). The cell nucleus was
counterstained with DAPI to show individual cells.vector particles prepared from JCV, LPV, and BKV capsid proteins
exhibit different abilities in transducing DNA to target cells, SV40
capsid being the most effective for TC7 and Vero cells, JCV for SVG
cells, and LPV for C2C12 cells.
Discussion
We have made SV40-based polyomaviral vectors by transfecting
293T cells with three sets of DNAs: DNA for the expression of SV40 T
antigen; DNA for the expression of SV40 capsid proteins, and vector
DNA harboring a reporter gene expression cassette carrying SV40 Ori.
Vectors generated in the transfected cells were examined by
sedimentation through 27%–39% Optiprep gradients and the respec-
tive peaks of Vp1 and DNA appeared in similar positions to the
virions. When observed under the electron microscope, the peak
fractions contained particles morphologically similar to the virion.
The composition of SV40 vector particles and the efﬁciency of
transducing DNA to the target cells were comparable to those of the
SV40 virion. Our method can produce vectors with no detectable
contamination with viable recombinants. Furthermore, with this
method we were able to produce vectors bearing capsid proteins of
JCV, LPV, or BKV, and the ability to transduce vector DNA to target
cells differed among different cell types, reﬂecting the tropisms of
the original viruses. Such polyomaviral vectors with exchangeable
capsids would be of beneﬁt in the development of surrogate systems
for studying viral capsid proteins of other polyomaviruses and in
targeted gene delivery systems.
Our results show that it is possible to prepare vector particles
bearing a capsid from any of the four different polyomaviruses—SV40,
JCV, BLV, and LPV. Since the polyomaviral capsid is known to play an
important role in determining the viral cell tropism (JCV: (Chen and
Atwood, 2002); LPV: (Haun et al., 1993; Herrmann, Oppenlander, and
Pawlita, 1995), capsid exchange could signiﬁcantly alter the cell
speciﬁcity of gene transfer. Indeed, our results indicate that the
vectors made of JCV and LPV capsids showed distinct and restricted
cell tropisms (Fig. 4). The tropism, however, was not always the same
as that of the original virus. In contrast to the tropism revealed in the
JCV capsid-bearing vector, which closely resembled to that of the
virion, tropism of LPV capsid vector did not strictly follow the tropism
of the virions. Unexpectedly, the LPV capsid vector showed efﬁcient
transduction into mouse myoblast cells. Although it is not known
whether the natural LPV virion can infect myoblasts, C2C12 cells
could share common cell surface receptors functionally equivalent to
those displayed in LPV-permissive cells. Transduction by BKV capsid-
bearing vectors to BKV-permissive Vero cells was moderate and with
lesser degree than that of SVG cells. It is known that human fetal glial
cells are also permissive to BKV infection (Takemoto et al., 1979), and
it is not surprising that SVG cells, originated from human fetal glial
cells, readily received BKV vectors. The BKV strain used in our study is
from archetypic strain and differences in the amino acid sequences of
the capsid proteins with the commonly used strain, MM and Dunlop,
are not signiﬁcant (Nishimoto et al., 2006). It is not known whether
such differences inﬂuence the cell tropism of the vector.
Other viral vector systems have taken advantage of exchangeable
viral capsid components of different serotypes exhibiting different cell
tropisms. Adenoviral vectors, most of which are derived from serotype
5, have been modiﬁed to carry ﬁber proteins of serotypes 35 and 11,
thus changing the cell surface receptor to which the vector binds from
CAR to CD34. This modiﬁcation allowed the vector to transduce genes
to cells that poorly displayed CAR but did display CD34, such as
hematopoietic cells (Shayakhmetov et al., 2002; Stecher et al., 2001).
Distinct cell tropisms are known among 11 different serotypes of
adeno-associated viral vectors, each of which is differentially used
depending on the target tissue (Gregorevic et al., 2004; Grimm and
Kay, 2003; Nakai et al., 2005). Both vector systems were examined in
an in vivo transfer system to determine the degree of targeting to a
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polyomaviral vectors and will be investigated in future.
We suggest that in 293T cells, the DNA episomally replicated by
SV40 T antigen can be readily packaged by non-SV40 capsid proteins.
The packaging efﬁciency of the vector DNA did not differ among
different capsids (Fig. 3A). It is known that JCV could do so, since a
variant of SV40 whose capsid coding region was replaced with that
of JCV forms fully infectious particles (Chen and Atwood, 2002). We
show here that capsids of BKV and LPV, i.e, other than those of JCV,
were able to package DNAwhose replication was mediated by SV40 T
antigen. Furthermore, bovine papillomavirus capsid proteins co-
expressed with SV40 T antigen can form particles packaging
episomally replicated DNA (Buck et al., 2004). Thus, it seems
plausible that capsids from other polyomaviruses can be used to
generate vector particles. Indeed, the capsids of murine polyoma-
virus and baboon polyomavirus SA12 can also be used to generate
vector particles (data not shown). This suggests that using the
method described here, the capsid protein of any polyomavirus could
be used to generate vector particles.
The present results show that the efﬁciency of DNA transduction by
SV40 vector particles was similar to that of the virion. A ﬁxed number of
particles, judged from the number of DNA copies, was applied to SV40
permissive cells and we found that the proportion of cells transduced
with the vector DNAwas similar to proportion of cells transduced with
the virion. Knowing that the composition of the particles—the
molecular ratio of capsid protein to DNA—was similar to that of the
virion, it is not surprising that the ability of vector particles to transduce
DNA to the cells was equivalent to that of virion. The results indicate
that our system can generate vector particles whose competence in
transducing the DNA into cells is similar to that of the wild-type virion.
SV40 vectors of the ﬁrst generation were particularly useful
because they are easy to prepare in high-titer stocks (Strayer and
Milano, 1996; Vera et al., 2004), but the vector preparations were
likely contaminated with viable recombinants (Oppenheim and Peleg,
1989). To prevent such contamination, an adenoviral vector expres-
sing SV40 capsid protein was introduced into Cos7 cells together with
a vector DNA carrying SV40 Ori to generate SV40 vectors (Fang et al.,
1997). In our system, viral genes were separated into three parts to
generate particles, and two recombination events must take place to
reconstruct wild-type-like DNA. Our results showed that such events
are unlikely to occur in ourmethod. Furthermore, ourmethod allowed
the production of the SV40 vector carrying DNA expressing ﬂuor-
escent proteins, which was not possible previously for unknown
reasons (Vera and Fortes, 2004), unless an in vitro packaging system
was used (Kimchi-Sarfaty et al., 2003). With minimal SV40-derived
sequence, we would be able to design a longer transgene with less
complication to that can be carried into vector DNA.
Recently new human polyomaviruses have been discovered: Wu
virus (Gaynor et al., 2007) and KI virus (Allander et al., 2007) were
found in respiratory secretions and nasopharyngeal aspirate samples,
respectively, and Merkel cell polyomavirus was found in a rare skin
cancer, Merkel cell carcinoma (Feng et al., 2008). Although it is not
known whether these viruses are human pathogens, our vector
productionmethodwould provide a surrogate system for studying the
functions of their capsids in the viral life cycle by which providing a
means of examining the roles of these viruses in associated diseases.
Materials and methods
Construction of DNAs
All sequences generated by PCR were veriﬁed by sequencing.
Relevant restriction sites in the primer sequences described are
underlined.
pCI-Ts was constructed by replacing the AvrII-to-ScaI fragment of
pSVp23a (Ishii et al., 1994) with the XbaI-to-NruI fragment ofpOG44 (Stratagene, La Jolla, CA), harboring the human cytomega-
lovirus immediate-early (hCMV) promoter to generate T antigen
expression plasmid.
All vector DNAs carried SV40 Ori including SV40 origin and
enhancer elements spanning SV40 nucleotides 5171–130 (Reddy et al.,
1978). pSEAP2, 5115 bp in size, carrying an expression cassette for
SEAP driven by the SV40 early promoter, was from Takara-Clontech
(Otsu, Shiga, Japan). pSR-ZG, about 4.2 kbp in size, was constructed by
inserting an EcoRI-to-NotI fragment from pZs Green-1 (Takara-
Clontech) into the corresponding site of pSRalpha (Takebe et al.,
1988). pSCMV-ZG, 5509 bp in size, was constructed from pCAG-ZG.
Brieﬂy, pCAG-ZG was constructed by inserting the EcoRI-to-Bsu36I
fragment from pZsGreen-1, encoding the ZsGreen gene, into the
corresponding site of pCAGGS (Niwa et al., 1991). Then, using pCAG-ZG
as the template, the fragment harboring the ZsGreen gene and rabbit
beta-globin polyadenylation-signal (PolyA) was ampliﬁed by PCR
using the primers 5′-CAAA GAATTC TGCAGTCGACGGT-3′ and 5′-GATT
CTCGAG AGCTTGGGCTGCAGGTCGAGGGAT-3′, digested with EcoRI
and XhoI, and ligated with two other fragments—the SpeI-to-EcoRI
fragment harboring the hCMV promoter excised from pAltermax II
(Promega, Madison, WI, USA) and the KpnI-to-AvrII fragment carrying
SV40 Ori from NOpSV40 (Ishii et al., 1994). The triple-ligated fragment
was inserted into the KpnI and EcoRI sites of pSEAP2, generating
pSCMV-ZG. SV40-luc was constructed by replacing the AvrII-to-BclI
fragment encoding T antigen genes of pUCSV40 (Ishizu et al., 2001),
with the NheI-to-XbaI fragment of pGL3-basic (Promega) encoding
the ﬁreﬂy luciferase gene. In the resulting construct, the AvrII and BclI
sites were replaced with the NheI and BglII sites, respectively, by the
overlappingmutagenesis technique (Ho et al., 1989). The primers used
for this particular cloning can be obtained from the authors upon
request. pSV40-luc was digested with BamHI and self-ligated to
reconstruct circular vector DNA before use for transfection as
described previously (Ishii et al., 1994).
pTRE-Vps was constructed from pTRE-tight (Takara-Clontech) by
introducing SV40 late gene region from 294 to 2593 (SV40 nucleotide
number) ampliﬁed by PCR using NO-pSV40 SRBSM (Li et al., 2003) as
the template, and set of primers; the forward primer hybridizing 243–
276 and the reverse primer hybridizing 2579–2593 introducing NotI
sites at the end of the fragment (5′-TAGTAGGCTA GCGGCCGC
AGATGTTCACTGCATTCTAGT-3′). The resulting fragment was digested
with KpnI and NotI, and inserted at the corresponding sites of pTRE-
tight (Takara-Clontech) to generate pTRE-Vps. pmTet-on was con-
structed from pTet-on (Takara-Clontech) by XhoI digestion and self-
ligation, which removed the fragment harboring SV40 Ori.
pCAG-SV40 was constructed by inserting two fragments via the
KpnI–BamHI sites to pCAG-ZG: the KpnI-to-NotI fragment harboring
the SV40 late gene region from pTRE-Vps, and the NotI-to-BamHI
fragment harboring rabbit globin PolyA from pCAG-ZG (see above);
pCAG-ZG had the SV40 origin and PolyA as the second expression
cassette, which was removed in the process of constructing pCAG-
SV40. pCAG-JCV was constructed from pCAG-SV40 by replacing the
KpnI–NotI fragment with a PCR fragment generated using pJC1–
4→pJCV (Howley et al., 1980) (Health Science Resources Bank, Osaka,
Japan) as the template and the following primers: 5′-ACGTCT
GGTACCGGT GGCCATGGTTCTTCGCCAGCTGT-3′ and 5′-ACGTCT
GCGGCCGC GGATCCGATTACAGCATTTTTGTCTGCAACTGTCC-3′; the
amplifying region carried all late genes of JCV encompassing JCV
nucleotides (NCBI accession number J02226) 277–2535. The inserted
fragment also carried the AgeI site (5′-ACCGGT-3′) overlapping the
KpnI site (5′-GGTACC-3′). Similarly, pCAG-BKV was constructed from
pCAG-JCV by replacing the AgeI-to-NotI fragment with the PCR
fragment generated by molecular clone of BKV KOM5 (a kind gift
from Dr. Y. Yogo, Tokyo University, Tokyo, Japan (Nishimoto et al.,
2006); NCBI accession number AB211374) as the template, and primers
5′-AATTAA ACCGGT ATGGTTCTGCGCCAGCTGTCACG-3′ and 5′-TTAATT
GCGGCCGC TGTTTAAAGCATTTT GGTTTGCAATTGTCC-3′. pCAG-BKV
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constructed from pCAG-SV40 by replacing the KpnI-to-NotI fragment
encoding the LPV late region, including enhancer elements and the
capsid coding region spanning LPV nucleotides 5059–2658 (NCBI
accession number M30540), ampliﬁcation using pLPV-P12 (kind gift
from Dr. M. Pawlita, Deutsches Krebsforschungszentrum, Heidelberg,
Germany (Haun et al., 1993)) as the template and the primers 5′-
NNNNNNACCGGT GGTACCC TAGGGTTGCCATAGTGATTTTGCAG-3′ and
5′-AATTAA GCGGCCGC TCAGCCTCACATATCATTTGATACAGGGAG-3′.
pSVLPV2 was constructed from NO-pSV40 SRBSM by replacing the
late gene region with the LPV capsid coding region from pCAG-LPV2
using the KpnI and NotI sites.
Cells
CV-1, Namalwa, and Vero cells were from the Health Science
Research Resources Bank (Osaka, Japan). TC-7 and SVG cells were
kindly provided by Dr. H. Kasamatsu, University of California, Los
Angeles, CA, USA, and Dr. W. Atwood, Brown University, Providence,
RI, USA, respectively. 293T, HepG2, C2C12, NIT-1, and B16-F10 (B16)
were from the American Tissue Culture Collection, Washington, DC,
USA. 293FT and Cos7L cells were from Invitrogen (Carlsbad, CA, USA).
The cells were cultured and maintained according to the instructions
provided by the respective sources.
Detection of capsid proteins and DNAs
Capsid proteins were detected by Western blotting as described
(Nakanishi et al., 2002). Brieﬂy, the denatured samples were
separated by 5%–20% gradient SDS-PAGE, transferred onto PVDF
membranes (Immobilon-P; Millipore, Billerica, MA, USA), and probed
for the respective rabbit antibodies followed by reaction with HRP-
conjugated anti-rabbit IgG antibody (Bio-Rad, CA, USA) and detecting
the signal by chemiluminescence (ECL-Plus; GE Healthcare Sciences,
UK). Anti-SV40 Vp1 and anti-SV40 Vp3 rabbit antisera, provided by
Dr. H. Kasamatsu were used to detect SV40 capsid proteins. Rabbit
anti-Vp1 antibodies for JCV and LPV were kindly provided by Dr.
Shishido-Hara (Kyorin University, Tokyo, Japan (Shishido-Hara et al.,
2004)) and Dr. M. Pawlita, respectively. BKV Vp1 was detected using
anti-SV40 Vp1 antiserum through its cross-reactivity with BKV Vp1.
The copy numbers of vector DNA were quantiﬁed with a real-time
PCR kit (Lightcycler; Roche Applied Biosciences, Basel, Switzerland)
using the primer set OriPCR1 (5′-AAGCCTCCTCACTACTTCTGGAATGCTC-
3′), which hybridizes the SV40 sequence 5201–5230, and OriPCR2 (5′-
AGCATGCATCTCAATTAGTCAGCAACCCATAGTCC-3′), which is comple-
mentary to 101–134 amplifying the 174-bp SV40 origin region common
to all vector DNAs and SV40 DNA. Hybrid DNA carrying SV40 Ori, SV40
early genes, and capsid protein genes from either JCV or LPV was
similarly quantiﬁed using the OriPCR primers. BKV DNAwas quantiﬁed
using the primer set 5′-TCTTTCCCCTATTAGGCCCTCAATGG-3′, which
hybridizes the BKV sequence 1166–1191, and 5′-CTCTCCTGAATGTA-
CAGTTTGTTG-3′, which is complementary to 1325–1302.
Vector particle production and viral particle preparation
Although having integrated copy of the SV40 T antigen expression
cassette, 293T and 293FT cells poorly support replication of the
transfected DNA carrying SV40 Ori (Buck et al., 2004). 293TT cells (a
kind gift from J. Schiller, NIH, Bethesda, MD, USA (Buck et al., 2004))
did support DNA replication, though transient transfection of pCI-Ts
gave better results in promoting vector DNA replication in our study
(Fig. S2, Supplementary data).
293T cells, plated at 6×106 cells in 10 cm dishes, were transfected
with one of four sets of DNAs: (A) 4 μg of pTRE-Vps, 2 μg of pmTet-on,
2 μg of pCI-Ts, and 4 μg of either pSEAP2 or pSR ZG; (B), 4 μg of SV40
and 8 μg of pUC119; (C) 4 μg of SV40-luc, 2 μg of pCI-Ts, and 6 μg ofpUC119; (D) 6 μg of either pCAG-SV40, pCAG-JCV, pCAG-BKV, or pCAG-
LPV2, 2 μg of pCI-Ts, and 4 μg of pSCMV-ZG. The cells were replated
onto 15 cm dishes 6–7 h after transfection and incubated for 68–72 h.
When transfectedwith DNA of set A, 5 μg/ml doxycyclinewas added to
induce Vp1 expression 24 h after transfection. After incubation, cells
were scraped off with a cell lifter and collected by centrifugation at
700 ×g at room temperature for 5min. The cell pellet was resuspended
in 1/40 culture volume of 10 mM Tris–HCl pH 7.5, 2 mM MgCl2, 0.25%
Brij 58 (Sigma, St. Louis, MO, USA), 5 U/ml of Benzonase (Sigma), and
protease inhibitor cocktail (Nakalai, Kyoto, Japan), and then incubated
for 30 min at 37 °C. The lysate was spun down at 2500 rpm at 4 °C for
5 min, and the supernatant was overlaid onto a 27%–39% Optiprep
continuous gradient in 10 mM HEPES at pH 7.5, prepared as described
by Buck et al. (2004). After ultracentrifugation at 45 krpm, for 3.5 h at
16 °C using a Beckman SW50.1 Ti rotor, 200-μl fractions were taken
from the top. To detect vector DNA peak fractions for SV40, JCV, BKV,
and LPV capsid vector particles, 1-μl aliquots from each fraction were
mixed with 9 μl of 0.02% trypsin and 0.025% EDTA and incubated for
10 min at 37 °C, and 1 μl of the 100-fold-diluted trypsin digest was
used as the template to amplify the SV40 origin region of the vector
DNA by PCR using PrimeStar enzyme (Takara) and OriPCR1 and
OriPCR2 as primers. The reactions were run on 1% agarose gel and the
PCR products were visualized by ethidium bromide staining.
The SV40 Vp1 or vector DNA peak fractions were pooled and
dialyzed in Dulbecco's PBS (−) to remove Optiprep, and ultracentri-
fuged using a Beckman SW50.1 Ti rotor at 45 krpm for 1 h at 4 °C. The
pellet was resuspended in 10 mM HEPES (pH 7.5) and 10 mM KCl in
the presence of protease inhibitor cocktail. The copy number of the
vector DNA present in the preparationwas quantiﬁed by real-time PCR
as described above.
SV40 and BKV virions were prepared from the viral DNA generated
from the respective molecular clones, pUCSV40 and pUCBKV KOM5
(Nishimoto et al., 2006), by digesting with BamHI and self-ligation.
Infectious particles carrying either JCV or LPV capsid were prepared
from the corresponding SV40 hybrid because of the difﬁculty of
propagation in cell culture. pBR SVJC (a kind gift from Dr. W. Atwood
(Chen and Atwood, 2002)) and pSVLPV2, which carry SV40's Ori and
the early genes but encode late genes of JCV and LPV, respectively,
were digested with BamHI and self-relegated to generate the
respective hybrid viral DNAs. The DNAs were transfected to 293T
cells and puriﬁed for particles in the same way as for the vectors
described above. To obtain enough number of BKV particles 1×109
293T cells were transfected with the viral DNA. The DNA peak
fractions identiﬁed by PCR were pooled and the amounts of DNAwere
quantiﬁed as described (see Detection of capsid proteins and DNAs).
Transduction assay
Tomeasure SEAP activity,15 μl of conditionedmediumwas assayed
for activity by chemiluminescence-based detection using the SEAP
assay kit (Takara) and a plate reader for measuring luminescence
(Powerscan HT; Dainippon Sumitomo Pharmaceuticals, Osaka, Japan).
To examine reporter or viral gene expression by an immunoﬂuores-
cence technique, cells grown in eight-well Labtek chamber slides
(Nunc, Rochester, NY, USA) were challenged with the respective
vectors, ﬁxed with 4% paraformaldehyde in Dulbecco's PBS (−), then
reacted with either rabbit anti-ZsGreen antibody (Takara) or rabbit
anti-SV40 Vp1 serum followed by reaction with Alexa Fluor 555 goat
anti-rabbit antibody (Invitrogen). The cells were observed with an
epiﬂuorescence microscope (BX60; Olympus, Tokyo, Japan) to detect
either ZsGreen autoﬂuorescence or Alexa Fluor 555 ﬂuorescence.
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